# Glycation Product Synthesized in Anhydrous Conditions Mimics an Epitope in Epithelial and Mesenchymal Tissues

**Authors:** Monika Czech, Elżbieta Gamian, Agata Kochman, Marta Woźniak, Emilia Jaskuła, Piotr Ziółkowski, Andrzej Gamian

PMC · DOI: 10.3390/biomedicines14010196 · Biomedicines · 2026-01-16

## TL;DR

This study explores a new epitope, AGE10, found in various tissues but not in certain tumors, suggesting limited potential as a diagnostic marker.

## Contribution

The study identifies the unique tissue distribution of the AGE10 epitope and its absence in muscular tumors.

## Key findings

- AGE10 is recognized in striated muscles and salivary glands but not in muscular tumors.
- AGE10 staining is cytoplasmic in both normal and cancerous tissues.
- AGE10 is present in adenomas of the large intestine but has limited diagnostic potential.

## Abstract

Background: Advanced glycation end-products (AGEs) are formed and deposited in tissues, contributing to various disorders, including diabetes, other metabolic diseases, and aging. A new epitope, AGE10, was identified in human and animal tissues using a monoclonal antibody raised against synthetic melibiose-derived glycation end-products (MAGE), which were synthesized under anhydrous conditions with bovine serum albumin or myoglobin. The biology of the AGE10 epitope, particularly its role in diseases and in cancer tissues, is not well understood. Methods: The study was aimed at investigating the immunohistochemical recognition of AGE10 with the MoAb-anti-MAGE antibody. Results: Data obtained show that AGE10 is recognized in striated muscles but not in tumors of muscular origin. AGE10 is also stained in both normal and cancerous salivary glands and in adenomas of the large intestine. The staining is cytoplasmic. Discussion: Our approach may provide a methodology for cell biology research; AGE10 may be related to an advanced lipoxidation end-product; further investigation of MAGE may clarify disease mechanisms, support the development of novel therapeutic strategies. Conclusions: The key finding is that antibodies recognize mainly the epitope in epithelial and some mesenchymal tissues. Thus, the potential for AGE10 as a diagnostic marker is limited. The implications concern the biology of this epitope, the unique tissue distribution, and a role in cellular metabolism.

## Linked entities

- **Proteins:** LOC105216124 (uncharacterized LOC105216124)
- **Chemicals:** melibiose (PubChem CID 440658)
- **Diseases:** diabetes (MONDO:0005015)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, MB (myoglobin) [NCBI Gene 4151] {aka MYOSB, PVALB}
- **Diseases:** adenomas of the large intestine (MESH:D007410), diabetes (MESH:D003920), metabolic diseases (MESH:D008659), cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12838804/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12838804/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12838804/full.md

---
Source: https://tomesphere.com/paper/PMC12838804